샘플 요청 목록

 카트 문의
시장보고서
상품코드
1606508

일본의 혈관외과 및 혈관내 수술 시장(2024-2031년)

Japan Vascular Surgery and Endovascular Procedures Market - 2024-2031
발행일: | 리서치사: DataM Intelligence | 페이지 정보: 영문 197 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

개요

일본의 혈관외과 및 혈관내 수술 시장은 2023년 1억 2,250만 달러에 달하고, 2031년에는 2억 2,400만 달러에 달할 것으로 예상되며, 2024년부터 2031년까지 연평균 7.9%의 CAGR로 성장할 것으로 예상됩니다.

혈관외과는 동맥, 정맥, 림프관 등 혈관계에 영향을 미치는 질환과 상태를 진단하고 치료하는 데 중점을 두는 의료 전문 분야입니다. 이러한 구조는 혈액과 림프가 몸 전체에 순환하는 데 필수적인 역할을 합니다. 혈관외과 전문의는 혈류를 회복하거나 막힌 혈관을 뚫기 위해 기존의 개복 수술과 최소침습 수술을 모두 시행합니다. 혈관 내 치료는 작은 구멍이나 절개를 통해 혈관 상태를 치료하는 최소침습적 기술입니다. 이 치료법에서는 카테터나 와이어와 같은 기구를 혈관에 통과시켜 개복 수술이 필요 없는 치료를 시행합니다.

일본의 혈관외과 및 혈관내 수술 시장 수요는 인구 고령화, 혈관 질환의 유병률 증가, 최소침습 기술의 발전 등의 요인으로 인해 꾸준히 성장하고 있습니다. 예를 들어, 일본혈관외과학회에 따르면, 동맥류 치료 분야에서는 총장골동맥류를 포함한 복부 대동맥류(AAA) 20,160건(61.6%)이 등록되어 있으며, 이 중 1,794건(8.9%)이 파열된 AAA로 등록되어 있으며, 이 중 61.6%가 혈관 내 동맥류 치료(EVAR)로 치료되고 있습니다. 파열된 AAA로 등록되었습니다.

시장 역학:

촉진요인과 억제요인

고령화 인구의 증가

고령화율의 증가는 일본 혈관외과 및 혈관내 수술 시장을 크게 견인하고 있으며, 예측 기간 동안에도 시장을 주도할 것으로 보입니다. 고령자 비율이 지속적으로 증가함에 따라 노인성 혈관 질환의 유병률도 증가하고 있습니다. 이러한 인구통계학적 변화는 전통적인 혈관 수술과 최소침습적 혈관 내 치료에 대한 수요에 큰 영향을 미치고 있습니다.

노년층으로 갈수록 말초동맥질환(PAD), 대동맥류, 정맥류, 뇌졸중 등 혈관 중재술이 필요한 질환에 걸리기 쉽습니다. 예를 들어, 세계경제포럼(WEF)에 따르면 일본은 점점 더 고령화되고 있습니다. 현재 국민 10명 중 1명 이상이 80세 이상입니다. 인구의 거의 3분의 1이 65세 이상이며, 그 수는 3,623만 명으로 추산됩니다. 뇌졸중 위험은 특히 고령자에게 많이 발생하는 혈관 질환인 경동맥 질환으로 인해 나이가 들어감에 따라 증가합니다.

혈관외과 및 혈관내 수술에 따른 높은 비용

혈관외과 및 혈관내 수술과 관련된 높은 비용은 예측 기간 동안 시장 성장을 저해할 것으로 예상됩니다. 스텐트, 이식편, 코일과 같은 혈관 내 장치는 제조 및 사용 비용이 많이 듭니다.

특수한 이식재와 영상 장비가 필요한 혈관 내 동맥류 치료(EVAR)의 비용은 기존 수술보다 훨씬 더 높을 수 있습니다. 예를 들어, 옥스포드 아카데미에 따르면, EVAR의 평균 의료비는 환자 한 명당 35,2000엔(한화)에 달했습니다.

또한, 국립보건연구원의 연구에 따르면, 개복수술(OR)과 EVAR의 평균 비용은 각각 632,370엔 대 490,050엔으로 진단적 시술 조합(DPC)에서 유의미한 차이를 보였으며, 마취는 각각 123,540엔 대 86,220엔, 재료는 각각 257,770엔 대 2,113,280엔이었습니다. 따라서 평균 총비용은 개복수술이 1,825,830엔, EVAR이 3,159,270엔이었습니다.

목차

제1장 조사 방법과 조사 범위

제2장 정의와 개요

제3장 주요 요약

제4장 시장 역학

  • 영향요인
    • 성장 촉진요인
      • 고령화 인구 증가
      • 최소침습 기술의 진보
    • 성장 억제요인
      • 혈관외과 및 혈관내 수술에 따른 고액의 비용
    • 기회
    • 영향 분석

제5장 산업 분석

  • Porter's Five Forces 분석
  • 공급망 분석
  • 가격 분석
  • 특허 분석
  • 규제 분석
  • SWOT 분석
  • 미충족 수요

제6장 시술별

  • 동맥류 수복
  • 바이패스 수술
  • 경동맥 성형술과 스텐트 삽입술
  • 혈관내 수복
  • 기타

제7장 제품 유형별

  • 스텐트와 스텐트 그래프트
  • 혈관내 툴
  • 가위와 겸자
  • 니들 홀더
  • 기타

제8장 최종사용자별

  • 병원
  • 외과 센터
  • 학술조사기관
  • 기타

제9장 경쟁 구도

  • 경쟁 시나리오
  • 시장 상황·점유율 분석
  • M&A 분석

제10장 기업 개요

  • Terumo Corporation
    • 기업 개요
    • 제품 포트폴리오와 개요
    • 재무 개요
    • 주요 발전
  • Olympus Corporation
  • FUJIFILM Holdings Corporation
  • Mizuho Medical Co., Ltd.
  • Nipro Corporation
  • Shimadzu Corporation
  • SB-KAWASUMI LABORATORIES, INC.
  • ASAHI INTECC CO., LTD.
  • Medtronic plc
  • Boston Scientific Corporation

제11장 부록

ksm 24.12.20

Overview

The Japan vascular surgery and endovascular procedures market reached US$ 122.5 million in 2023 and is expected to reach US$ 224.0 million by 2031, growing at a CAGR of 7.9% during the forecast period 2024-2031.

Vascular surgery is a medical specialty focused on diagnosing and treating diseases and conditions affecting the vascular system, which includes arteries, veins, and lymphatic vessels. These structures are essential for circulating blood and lymph throughout the body. Vascular surgeons perform both traditional open surgeries and minimally invasive procedures to restore blood flow or remove blockages in the vessels. Endovascular procedures are minimally invasive techniques used to treat vascular conditions through small punctures or incisions. These procedures involve the use of catheters, wires, and other devices guided through blood vessels to perform treatments without the need for open surgery.

The market demand for vascular surgery and endovascular procedures in Japan has been growing steadily, driven by factors such as the aging population, rising prevalence of vascular diseases, and advancements in minimally invasive technologies. For instance, according to the Japanese Society for Vascular Surgery, in the field of aneurysm treatment, 20,160 cases of abdominal aortic aneurysm (AAA) including common iliac aneurysms were registered, and 61.6% were treated by endovascular aneurysm repair (EVAR). Among AAA cases, 1,794 (8.9%) cases were registered as ruptured AAA.

Market Dynamics: Drivers & Restraints

Rising aging population

The rising aging population is significantly driving the Japan vascular surgery and endovascular procedures market and is expected to drive the market over the forecast period. As the proportion of elderly people continues to rise, there is an increased prevalence of vascular diseases, which are more common among older individuals. This demographic shift is significantly impacting the demand for both traditional vascular surgery and minimally invasive endovascular treatments.

As people age, they are more susceptible to conditions like peripheral arterial disease (PAD), aortic aneurysms, varicose veins, and stroke all of which often require vascular interventions. For instance, according to the World Economic Forum, Japan is getting ever greyer. More than 1 in 10 people in the country are now aged 80 or older. Almost a third of its population is over 65 - an estimated 36.23 million. Stroke risk rises with age, particularly due to carotid artery disease, which is a common vascular condition in older people

High cost associated with vascular surgery and endovascular procedures

The high cost associated with vascular surgery and endovascular procedures is expected to hamper the growth of the market over the forecast period. Endovascular Devices such as stents, grafts, and coils are expensive to manufacture and use.

The cost of Endovascular Aneurysm Repair (EVAR), which requires specialized grafts and imaging equipment, can be significantly higher than traditional surgery. For instance, according to the Oxford Academy, the average medical cost for EVAR was 35,2000 Japanese Yen per patient.

Additionally, according to a study conducted by the National Institute of Health, the mean costs for open surgical repair (OR) versus EVAR were as follows, Diagnosis Procedure Combination (DPC) ¥632,370 versus ¥490,050, respectively, which was significant; anesthesia, ¥123,540 versus ¥86,220, respectively and materials, ¥257,770 versus ¥2,113,280, respectively. Thus, the mean total cost was ¥1,825,830 versus ¥3,159,270 for open repair and EVAR, respectively.

Segment Analysis

The Japan vascular surgery and endovascular procedures market is segmented based on procedure, product type and end-user.

Procedure:

The endovascular repair segment is expected to dominate the Japan vascular surgery and endovascular procedures market share

The endovascular repair segment holds a major portion of the Japan vascular surgery and endovascular procedures market share and is expected to continue to hold a significant portion of the market share over the forecast period. Endovascular repair involves the use of minimally invasive techniques to treat vascular conditions such as abdominal aortic aneurysms (AAA) and peripheral arterial disease (PAD). These procedures use small incisions or punctures, making them far less invasive than traditional open surgery.

The demand for EVAR has surged in Japan as patients prefer less invasive procedures that offer faster recovery times and shorter hospital stays. For instance, according to the J-Stage, as of 2020, EVAR accounted for over 60% of AAA cases in Japan, indicating its dominance in the treatment of aneurysms.

Endovascular repair has benefited from technological innovations in medical devices, imaging, and procedural techniques. The introduction of advanced stents, drug-eluting balloons and robotic-assisted navigation has made endovascular repair even more efficient, safe, and accessible. This has contributed to the widespread adoption of these procedures across Japan.

Competitive Landscape

The major Japan players in the vascular surgery and endovascular procedures market include Terumo Corporation, Olympus Corporation, FUJIFILM Holdings Corporation, Mizuho Medical Co., Ltd., Nipro Corporation, Shimadzu Corporation, SB-KAWASUMI LABORATORIES, INC., ASAHI INTECC CO., LTD., Medtronic plc, Boston Scientific Corporation and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan vascular surgery and endovascular procedures market report would provide approximately 39 tables, 31 figures and 197 pages.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Procedure
  • 3.2. Snippet by Product Type
  • 3.3. Snippet by End-User

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Aging Population
      • 4.1.1.2. Advancements in Minimally Invasive Techniques
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost Associated with Vascular Surgery and Endovascular Procedures
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Procedure

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 6.1.2. Market Attractiveness Index, By Procedure
  • 6.2. Aneurysm Repair*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Bypass Surgery
  • 6.4. Carotid Angioplasty and Stenting
  • 6.5. Endovascular Repair
  • 6.6. Others

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Stents and Stent Grafts*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Endovascular Tools
  • 7.4. Scissors and Forceps
  • 7.5. Needle Holders
  • 7.6. Others

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hospitals
  • 8.4. Surgical Centers
  • 8.5. Academic and Research Institutions
  • 8.6. Others

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. Terumo Corporation*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Financial Overview
    • 10.1.4. Key Developments
  • 10.2. Olympus Corporation
  • 10.3. FUJIFILM Holdings Corporation
  • 10.4. Mizuho Medical Co., Ltd.
  • 10.5. Nipro Corporation
  • 10.6. Shimadzu Corporation
  • 10.7. SB-KAWASUMI LABORATORIES, INC.
  • 10.8. ASAHI INTECC CO., LTD.
  • 10.9. Medtronic plc
  • 10.10. Boston Scientific Corporation

LIST NOT EXHAUSTIVE

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제